<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../figures/favicon.png" type="image/x-icon">
  <title>Ovarian Tumors (Benign and Malignant)</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="/style.css">
  <link rel="stylesheet" href="/notes.css">
</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="/index.html">
    <div class="home-navigation">
      M
    </div>
  </a>

  <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="/index.html">Home</a>
      </li>
      <li class="menu__item">
        <a class="menu__link" href="/about-temp2.html">About</a>
      </li>
      
     
      

      <!-- <li class="menu__item">
        <a class="menu__link" href="#0">Projects</a>
        <ul class="submenu">
          <li class="menu__item">
            <a class="menu__link" href="/404.html">Surgery</a>
          </li>
          <li class="menu__item">
            <a class="menu__link" href="/404.html">Pediatrics</a>
          </li>
        </ul>
      </li> -->
    </ul>
  </nav>
  
  <main class="page-container">
    <!-- <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="/contribute.html">Contribute here</a> </span>
    </div> -->

    <h1>Ovarian Tumors (Benign and Malignant)</h1>
  
    <!-- <div class="author-flex">
      <div class="author-img">
        <img  src="/contributors/vt1.jpeg" alt="">
      </div>
      <div>
        <h2 class="name">Compiled by Victortayo</h2>
        <p class="updated">last updated, Nov 2022</p>
      </div>
    </div> -->

    <article class="notes">
        <a id='top'></a>
    <article>
    <!-- <h2 class='title'>Outline</h2> -->
    <label class="trigger outline">
        <input type="checkbox" class="checkbox checkbox--red" /> Show/hide outline
        <div class="msg">
         <ol>
            <li><a href="#header-1">Introduction</a></li>
            <li><a href="#header-2">Benign Ovarian Tumors</a></li>
            <ul>
                <li><a href="#heading-2-1">	Physiologic Benign Ovarian Tumors</a></li>
                <li><a href="#heading-2-2">	Pathologic Benign Ovarian Tumors</a></li>
                <li><a href="#heading-2-3">	Clinical features/signs</a></li>
                <li><a href="#heading-2-4">	Investigations</a></li>
                <li><a href="#heading-2-5">	Complications</a></li>
                <li><a href="#heading-2-6">	Differential diagnosis</a></li>
                <li><a href="#heading-2-7">	Treatment</a></li>
            </ul>
            <li><a href="#header-3">Malignant Ovarian Tumors</a></li>
            <ul>
                <li><a href="#heading-3-1">	Incidence</a></li>
                <li><a href="#heading-3-2">	Etiological/risk factors</a></li>
                <li><a href="#heading-3-3">	Clinical features</a></li>
                <li><a href="#heading-3-4">	Types/classification</a></li>
                <li><a href="#heading-3-5">	Investigation</a></li>
                <li><a href="#heading-3-6">	Staging</a></li>
                <li><a href="#heading-3-7">	Treatment</a></li>
                <li><a href="#heading-3-8">	Prognosis</a></li>
            </ul>
            <li><a href="#header-4"></a>Tumors of Borderline Malignancy</li>
         </ol>
        </div>
      </label>

      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction </a>
          </h2>
        </header>
        <div class='body'>
            <p>Ovary contain numerous cell types therefore has the most varied type of growth/cyst</p>
            <p>Size/position not easily accessible.</p>
            <p>No premalignant stage has been identified.</p>
        </div>

      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Benign ovarian tumors</a>
          </h2>
        </header>
        <div class='body'>
            <p>They can be</p>
            <ul>
                <li>Physiologic, or</li>
                <li>Pathologic</li>
            </ul>
            <p>Could be during pregnancy</p>
            <p>Usually occur within the reproductive age</p>
            <p>Can present as acute abdominal emergency</p>
            <p>Amenable to surgery-cystectomy or ovariectomy</p>
            <p>Do not usually reoccur</p>
          <section id='heading-2-1'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-1'>Physiologic Benign Ovarian Tumors</a>
              </h3>
            </header>
            <div class='body'>
               <ul>
                <li>Follicular Cysts: </li>
                <li>Corpus-luteum Cysts</li>
                <li>Theca ‚Äì lutein-cyst</li>
               </ul>

               <h4><span class="special-text-4">1. Follicular Cysts: </span></h4>
               <ul>
                <li>Common</li>
                <li>Enlarged unruptured follicules</li>
                <li>Linings secrete fluid</li>
                <li>Usually < 5cm</li>
                <li>Asymptomatic </li>
                <li>Unilateral</li>
                <li>Occasionally may cause menstrual irregularities </li>
                <li>Rarely persist beyond 3 months</li>
                <li>No treatment needed</li>
               </ul>

               <h4><span class="special-text-4">2. Corpus-luteum Cysts</span></h4>
               <ul>
                <li>Normal corpus lutuem can become cystic especially following hemorrhage</li>
                <li>Corpus luteum of pregnancy can become quite large</li>
                <li>Can cause short period of amenorrhea and prolong bleeding</li>
                <li>Treatment is usually conservative unless it becomes large, or undergoes complication.</li>
               </ul>

               <h4><span class="special-text-4">3. Theca ‚Äì lutein-cyst</span></h4>
               <ul>
                <li>Usually bilateral</li>
                <li>Seen in association with trophoblastic dis</li>
                <li>Ovulation induction drugs</li>
                <li>May cause pain</li>
                <li>Management usually conservative</li>
               </ul>

               <h4><span class="special-text-4">Ovarian cysts in pregnancy</span></h4>
               <ul>
                <li>1 in 1000-1500 pregnancy</li>
                <li>1 in every 10 are physiological</li>
                <li> Management usually conservative</li>
                <li>They often resolve</li>
               </ul>

               <h4><span class="special-text-4b">Pathological cysts in pregnancy</span></h4>
               <ul>
                <li>> 50% are cystic teratoma & mucinous cysts adenoma</li>
                <li>Assessment‚Äî clinical, by USS</li>
                <li>Surgery usually not done in 1st trimester </li>
                <li>If problematic, surgery can be done 12-18 weeks</li>
                <li>Otherwise can be done after delivery.</li>
               </ul>


            </div>
          </section>

          <section id='heading-2-2'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-2'>Pathologic (Neoplastic) Benign Ovarian Tumors</a>
              </h3>
            </header>
            <div class='body'>
               <p>The ovarian tissue are constantly in a dynamic state.</p>
               <p>Main tissues of the ovary are:</p>
               <ul>
                <li>Epithelial cells from coelomic epithelium</li>
                <li>Oocytes from primitive germ cell</li>
                <li>Mesenchymal elements from gonadal stroma</li>
               </ul>
               <p>Epithelial cell tumors are the commonest </p>
               <p>Some can get really big (39kg the biggest in our center [UITH])</p>
               <p>They are usually amenable to surgery and do not recur</p>
               <p>What surgery is done is dependent on age and parity of patient</p>

               <h4><span class="special-text-4">Classification</span></h4>
               <ul>
                <li>Epithelial tumors</li>
                <li>Sex cord stromal tumors- granulosa cell, thecoma fibroma group, sertoli cell tumors</li>
                <li>Germ cell tumors- dysgerminoma, endodermal sinus tumors, embryonal cell tumor, teratoma- immature and mature (dermoid cyst), carcinoid and mixed form</li>
                <li>Gonadoblastoma</li>
               </ul>

               <h4><span class="special-text-4">Epithelial Tumor</span></h4>
               <p>Commonest form of neoplasm, called adenomas </p>
               <p>Examples are</p>
               <ul>
                <li>Serous cyst adenoma</li>
                <li>Mucinous cyst adenoma</li>
                <li>Endometroid</li>
                <li>Brenner</li>
                <li>etc.</li>
               </ul>

               <h4><span class="special-text-4b">Serous cyst adenoma- </span></h4>
               <ul>
                <li>Common</li>
                <li>From the totipotential cells of epithelium</li>
                <li>Can be bilateral</li>
                <li>Cells resemble endosalpinx</li>
               </ul>

               <h4><span class="special-text-4b">Mucinous cyst adenoma-</span></h4>
               <ul>
                <li>Resemble cells lining of endocervix</li>
                <li>Totipotentail cells of epithelium of the ovary</li>
                <li>Can attain very large size is the largest ovarian tumor</li>
                <li>Secretes mucin</li>
                <li>Can be bilateral.</li>
               </ul>

               <h4><span class="special-text-4">Germ Cell Tumor</span></h4>
               <h4><span class="special-text-4b">Dermoid cyst-</span></h4>
               <ul>
                <li>Germ cells arrested after 1st meiotic division</li>
                <li>Commonest form of teratomas</li>
                <li>Bilateral in 15-20%</li>
                <li>20-40% ovarian tumor in pregnancy</li>
                <li>Contains sebaceous material, hair, CSF, teeth, bone</li>
                <li>When it contains mainly thyroid tissue is called stroma ovarii (rare, can cause hyperthyroidism) </li>
                <li>Common complication is torsion</li>
                <li>Rupture not common</li>
               </ul>


            </div>
          </section>

          <section id='heading-2-3'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-3'>Clinical features/sign</a>
              </h3>
            </header>
            <div class='body'>
               
                <h4><span class="special-text-4">Clinical features</span></h4>
                <ul>
                    <li>Mainly during reproductive life</li>
                    <li>No correlation with parity</li>
                    <li>Most are asymptomatic </li>
                    <li>May have mass in lower abdomen, can become huge</li>
                    <li>Pain/discomfort</li>
                    <li>Menstrual pattern usually undisturbed</li>
                    <li>Patients often look healthy even in huge ones</li>
                </ul>

                <h4><span class="special-text-4">Signs </span></h4>
                <ul>
                    <li>May have edema, generally patient is very healthy despite the size such that she may be mistaken to be pregnant.</li>
                    <li>Abdominal distension</li>
                    <li>Vaginal examination, uterus usually separate, and mass is often mobile</li>
                </ul>
            </div>
          </section>

          <section id='heading-2-4'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-4'>Investigations</a>
              </h3>
            </header>
            <div class='body'>
               <ul>
                <li>USS</li>
                <li>Hemogram</li>
                <li>Other special investigations</li>
                <li>CT scan, cytology, Xray</li>
               </ul>
            </div>
          </section>

          <section id='heading-2-5'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-5'>Complications</a>
              </h3>
            </header>
            <div class='body'>
               <ul>
                <li>Usually present as emergencies </li>
                <li>Torsion ‚Äì commonest</li>
                <li>Rupture</li>
                <li>Hemorrhage</li>
                <li>Infection </li>
               </ul>
            </div>
          </section>

          <section id='heading-2-6'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-6'>Differential diagnosis</a>
              </h3>
            </header>
            <div class='body'>
               <ul>
                <li>Full bladder</li>
                <li>Pregnancy</li>
                <li>Fibroid</li>
                <li>Ectopic kidney</li>
               </ul>
            </div>
          </section>

          <section id='heading-2-7'>
            <header>
              <h3>
                <a aria-hidden href='#heading-2-7'>Treatment</a>
              </h3>
            </header>
            <div class='body'>
               <p>Usually amenable to surgery</p>
               <p>Exploratory laparatomy</p>
               <p>What is done is dependent on age, parity</p>
               <p>Can be </p>
               <ul>
                <li>Cystectomy</li>
                <li>Ovariectomy</li>
                <li>TAH/BSO</li>
               </ul>
            </div>
          </section>


        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Malignant Ovarian Tumors</a>
          </h2>
        </header>
        <div class='body'>
            <section id='heading-3-1'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-1'>Incidence </a>
                  </h3>
                </header>
                <div class='body'>
                   <p>Ovarian cancer accounts for 3-4% of cancer in women but is the leading cause of death from gynecological cancer in the United States.</p>
                   <p>Rate ‚Äì higher in developed countries (11.5-15.3 vs 3.3-7.8/100,000) </p>
                   <p>Life time risk of women with no familial risk is 1.4% (1 in 70)</p>
                   <p>Not common before 40 years</p>
                   <p>Peak incidence 65-75 yrs.</p>
                </div>
              </section>

              <section id='heading-3-2'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-2'>Etiological/risk factors</a>
                  </h3>
                </header>
                <div class='body'>
                <h4><span class="special-text-4">Etiological factors</span></h4>
                   <p>Cause is unknown</p>
                   <p> Multifactorial </p>
                   <p>Theories of pathogenesis</p>
                   <ul>
                    <li>Incessant ovulation.     </li>
                    <li>Gonadotropin stimulation </li>
                    <li>Pelvic contamination  </li>
                   </ul>

                   <h4><span class="special-text-4">Risk Factors</span></h4>
                   <h4><span class="special-text-4b">Increased risk</span></h4>
                   <p>Patient characteristics</p>
                   <ul>
                    <li>Increasing age/Old age ‚Äì 65-75 years of age</li>
                    <li>Personal history of breast/endometrial cancer</li>
                   </ul>

                   <p>Genetic factors</p>
                   <ul>
                    <li>Family history of ovarian cancer: 10-15% has familial tendency. 90% occur sporadically.</li>
                    <li>BRCA 1/2 mutations</li>
                    <li>Hereditary non-polyposis colorectal cancer (Lynch syndrome)</li>
                   </ul>

                   <p>Reproductive factors</p>
                   <ul>
                    <li>Nulliparity/Infertility </li>
                    <li>Early menarche</li>
                    <li>Late menopause</li>
                    <li>Polycystic ovarian syndrome</li>
                    <li>Endometriosis  </li>
                   </ul>

                   <p>Environmental factors</p>
                   <ul>
                    <li>Obesity and high-fat diet (weak evidence)</li>
                    <li>Cigarette smoking (for mucinous ovarian cancer)</li>
                   </ul>
                   <p>Race?</p>

                   <h4><span class="special-text-4b">Reduced risks/protective factors</span></h4>
                   <p>Reproductive factors</p>
                   <ul>
                    <li>Use of oral contraceptives</li>
                    <li>Pregnancy/multiparity</li>
                    <li>Breastfeeding</li>
                   </ul>

                   <p>Gynecological surgery</p>
                   <ul>
                    <li>Salpingo-oophorectomy</li>
                    <li>Tubal ligation </li>
                   </ul>



                </div>
              </section>

              <section id='heading-3-3'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-3'>Clinical Features</a>
                  </h3>
                </header>
                <div class='body'>
                  <ul>
                    <li>Usually early symptoms are non-specific</li>
                    <li>Up to 80% present late</li>
                    <li>Indigestion, bloating, easy satiety/anorexia</li>
                    <li>Pressure symptoms and pain in pelvis and back</li>
                    <li>Swelling from mass or ascites</li>
                    <li>Weight loss</li>
                    <li>Abnormal vaginal bleeding </li>
                  </ul>
                  <h4><span class="special-text-4b">Findings: </span></h4>
                  <ul>
                    <li>Cystic, smooth unilateral, mobile, non-tender (benign) </li>
                    <li>Fixed, bilateral, nodular, solid + ascites suggest malignancy</li>
                  </ul>

                </div>
              </section>

              <section id='heading-3-4'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-4'>Types/classification</a>
                  </h3>
                </header>
                <div class='body'>
                   <p>Wider variety of tumors than any other organ.</p>
                   <p>Based on tissue of origin (i.e histopathologic)</p>
                   <ul>
                    <li>Epithelial ‚Äì serous, mucinous, endometroid, clear cell, Brenner</li>
                    <li>Sex cord/stromal‚Äî granulosa- theca cell tumour, Sertoli-leydig cell tumour, unclassified.</li>
                    <li>Germ cell‚Äî Dysgerminoma, endodermal sinus tumor, embryonal carcinoma, teratomas, mixed tumor.</li>
                    <li>Soft tissue tumor not specific to ovary</li>
                    <li>Unclassified</li>
                    <li>Metastatic </li>
                   </ul>

                   <h4><span class="special-text-4">Epithelial cell tumors</span></h4>
                   <ul>
                    <li> Derived from ovarian surface epithelial cells.</li>
                    <li> 90% of ovarian cancers</li>
                    <li>Serous cystadenocarcinoma (> 50%)</li>
                    <li>Bilateral (30-60%)</li>
                    <li>Up to 85% associated with extra ovarian spread at diagnosis</li>
                    <li>> 50% exceed 15cm in diameter</li>
                    <li>Histologically ‚Äì endosalpinx</li>
                    <li>Mostly unilocular but can be multilocular (up to 1/3)/li>
                   </ul>

                   <h4><span class="special-text-4b">Mucinous cysts adenocarcinoma</span></h4>
                   <ul>
                    <li> 10 - 15% all epithelial cancer</li>
                    <li>35% borderline malignancy</li>
                    <li>Can attain very large size </li>
                    <li>Average size 18-20cm</li>
                    <li>Usually multilocular cyst filled with viscous mucin</li>
                    <li>Resembles epithelial Ca cells of endocervix</li>
                    <li>Note ‚Äúpseudomyxoma peritonei‚Äù</li>
                   </ul>

                   <h4><span class="special-text-4b">Endometroid </span></h4>
                   <ul>
                    <li>10-25% of epithelial Ca</li>
                    <li>Bilateral in 30-50%</li>
                    <li>Associated with endometriosis ‚Äìabout 10%</li>
                    <li>Cells ‚Äì resemble endometrial cells/glands</li>
                    <li>Can have coexisting primary endometrial ca in up to 30%</li>
                    <li>Non epithelial tumors account for 10% </li>
                   </ul>

                   <h4><span class="special-text-4">Germ Cell Tumours</span></h4>
                   <ul>
                    <li>Up to 25% of ovarian tumors but malignant ones are rare < 3%.</li>
                    <li>Malignancy more common in children and in reproductive age.</li>
                   </ul>

                   <h4><span class="special-text-4">Sex Cord Stromal Tumors</span></h4>
                   <p>From cells in the gonad, in gonadal mesenchyme or the stroma 5-8%</p>
                   <h4><span class="special-text-4b">Granulosa Cell Tumour</span></h4>
                   <ul>
                    <li>Most common (70%)</li>
                    <li>Hormonally active</li>
                    <li>Can occur in any age group, but more in post-menopausal</li>
                    <li>Precocious puberty in young girls</li>
                    <li>Post-menopausal bleeding in elderly</li>
                    <li>Irregular bleeding in reproductive age.</li>
                   </ul>

                   <h4><span class="special-text-4b">Sertoli-Leydig cell tumour</span></h4>
                   <ul>
                    <li>Rare</li>
                    <li>Potentially malignant</li>
                    <li>Virilization may occurs if androgens are produced.</li>
                   </ul>

                   <h4><span class="special-text-4b">Fibromas</span></h4>
                   <ul>
                    <li>From stromal cells, composed of fibrous tissue</li>
                    <li>> 40% are up to 10cm</li>
                    <li>Rarely malignant</li>
                   </ul>
                   <p> NOTE: Meigs syndrome- an uncommon presentation where a benign ovarian tumor presents along with ascites and pleural effusion. About 1% of ovarian tumors can present as Meigs syndrome.</p>

                   <h4><span class="special-text-4">Secondary Tumors </span></h4>
                   <ul>
                    <li>Usually from GIT, from breast, uterus/cervix </li>
                    <li>Note Krukenberg tumours ‚Äì secondarily from stomach: usually solid, contain ‚Äòsignet cells‚Äô</li>
                   </ul>

                </div>
              </section>

              <section id='heading-3-5'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-5'>Differential diagnosis</a>
                  </h3>
                </header>
                <div class='body'>
                   <p>Influenced by age of patient</p>
                   <p>Characteristics of mass on exam</p>
                   <p>Colonic tumor</p>
                   <p>Kidney (pelvic)</p>
                   <p>Retroperitoneal tumor</p>
                   <p>Mesenteric tumor</p>
                </div>
              </section>

              <section id='heading-3-6'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-6'></a>
                  </h3>
                </header>
                <div class='body'>
                   <p>Blood:			</p>
                   <ul>
                    <li>FBC</li>
                    <li>E,u,Cr</li>
                    <li>Serum CA125 (elevated in >80% epitehelial)</li>
                   </ul>
                   <p>Radiological:</p>
                   <ul>
                    <li>Ultrasound ‚Äì can help to differentiate benign & malignant</li>
                    <li>Plain xray abdomen/chest </li>
                    <li>IVU</li>
                    <li>Barium enema,/Barium  swallow & follow through</li>
                    <li>CT scan ‚Äì retroperitoneal nodes</li>
                    <li>MRI </li>
                   </ul>
                </div>
              </section>

              <section id='heading-3-7'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-7'>Staging </a>
                  </h3>
                </header>
                <div class='body'>
                  <h4><span class="special-text-4">Surgical Evaluation</span></h4>
                  <p>The staging of ovarian cancer is done during exploratory laparotomy</p>
                  <ul>
                    <li>Ascitic fluid or peritoneal washing </li>
                    <li>Complete exploration</li>
                    <li>Removal of intact tumor
                    <li>Sampling from peritoneal seedling</li>
                    <li>Sample peritoneal surface</li>
                    <li>Pelvic & para-aortic nodes biopsies</li>
                    <li>Debulking procedure if possible</li>
                  </ul>

                  <h4><span class="special-text-4">Staging of Ovarian Tumor</span></h4>
                  <h4><span class="special-text-4b">I‚Äî Limited to ovary/ovaries</span></h4>
                  <ul>
                    <li>Ia ‚Äì one ovary involved; no ascites, no tumor on surface, capsule intact</li>
                    <li>Ib ‚Äì both ovaries</li>
                    <li>Ic ‚Äì a or b with ovarian surface tumour, ruptured capsules, malignant ascites or the positive peritoneal washing</li>
                  </ul>

                  <h4><span class="special-text-4">II‚Äî Extension of the growth to pelvis</span></h4>
                  <ul>
                    <li>IIa ‚Äì fallopian tube + uterus</li>
                    <li>IIb ‚Äì extension to other pelvic tissues</li>
                    <li>IIc ‚Äì a or b with surface tumor, ruptured capsule, ascites, or positive peritoneal washing</li>
                  </ul>

                  <h4><span class="special-text-4">III‚Äì Disease extension to the abdominal cavity</span></h4>
                  <ul>
                    <li>	IIIa ‚Äì abdominal peritoneal surface with microscopic metastasis</li>
                    <li>  	IIIb ‚Äì Metastasis < 2cm</li>
                    <li>	IIIc ‚Äì Metastasis > 2cm or positive para-aortic or inguinal lymp nodes.</li>
                  </ul>

                  <h4><span class="special-text-4">IV‚Äì Distant metastasis </h4>
                  <ul>
                    <li>	 Malignant pleural effusion</li>
                    <li>	 Pulmonary parenchymal disease</li>
                    <li>	 Liver/spleen parenchyma metastasis</li>
                    <li>	Metastasis, +ve supraclavicular nodes</li>
                  </ul>

                </div>
              </section>

              <section id='heading-3-8'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-3-8'>Treatment</a>
                  </h3>
                </header>
                <div class='body'>
                  <h4><span class="special-text-4">Surgery</span></h4>
                   <p>Surgery is the main treatment modality for ovarian cancer.</p>
                   <p>Epithelial Cancers: > 70% has stage III </p>
                   <p>Stages I ‚Äì II: Total abdominal hysterectomy, bilateral salpingo-oophorectomy and infracolic omentectomy.</p>
                   <ul>
                    <li>Post-operative: chemotherapy</li>
                   </ul>
                   <p>Stage IV ‚Äì Inoperable ‚Äì usually debulking if possible, followed by chemotherapy </p>
                   <ul>
                    <li>Note: interval debulking</li>
                   </ul>

                   <h4><span class="special-text-4b">Conservative Surgery</span></h4>
                   <p>Young women with early stage (Ia) cancer or borderline tumor who wishes to have family</p>
                   <p>Important to stage properly</p>
                   <p>Unilateral salpingo-oophrectomy is done</p>
                   <p>Removal of other ovary after completing family</p>

                   <h4><span class="special-text-4">Chemotherapy</span></h4>
                   <h4><span class="special-text-4b">Germ cell</span></h4>
                   <ul>
                    <li>Responds well to chemotherapy </li>
                    <li>Single agent ‚Äì cisplatinum</li>
                    <li>Combination agent ‚Äì platinum based adriamycin/cyclophosphomide</li>
                    <li>Taxol ‚Äì also very good.</li>
                   </ul>

                   <h4><span class="special-text-4">Radiotherapy</span></h4>
                   <p> Use limited</p>
                   <p>Pure dysgerminomas ‚Äì radiosensitive</p>
                   <p>Can be given as palliative treatment</p>

                </div>
              </section>
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Prognosis</a>
          </h2>
        </header>
        <div class='body'>
            <p>Poor ‚Äì because of late diagnosis</p>
            <p>Depends on stage/size of residual tumors (> 2cm).</p>

            <h4><span class="special-text-4">5 years survival</span></h4>
            <p>Stage I ‚Äì up to 70%</p>
            <p>Stage II ‚Äì 45%</p>
            <p>Stage IV < 5%</p>
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Prevention</a>
          </h2>
        </header>
        <div class='body'>
            <p>Ovarian screening</p>
            <p>No single standard</p>
            <p>Those with strong history</p>
            <p>Rectovaginal examination annually</p>
            <p>  Transvaginal ultrasound (TVS)</p>
            <p> Ca 125 test</p>
            <p>Prophylactic oophorectomy can be done</p>
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Tumors of Borderline Malignancy</a>
          </h2>
        </header>
        <div class='body'>
           <p>These are epithelial tumor which are intermediate in behavior and histological features between malignant and benign tumor</p>
           <p>10-15%</p>
           <p>Have good prognosis</p>
           <p>Management of early stage is conservative surgery</p>
           <p>But any spread out of pelvis is treated with total surgery.</p>
        </div>
      </section>



      </section>

      <div class="contact">
        <hr style="margin: 3rem 0;">

        <!-- <p>Send us a <a href="mailto:obgyn.materia@gmail.com"><span class="special-text-2">mail</span></a> at 
         <br> obgyn.materia@gmail.com.</p>
        <p>Or send your comments, corrections, explanations/clarifications and requests/suggestions to our 
         <br> <a href="" class="special-text-2" style="text-decoration: none;">WhatsApp group</a>.</p> -->
      </div>
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p>obgyn.materia.[beta]</p>
          
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="/main.js"></script>
</body>
</html>
 
